A Trial of SHR - 1906 in Healthy Subjects
NCT04986540
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
72
Enrollment
INDUSTRY
Sponsor class
Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG:
SHR-1906；Placebo
Sponsor
Guangdong Hengrui Pharmaceutical Co., Ltd